Protect Pharmaceutical Corporation
PRTT · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.25 | -0.08 | -0.01 | 0.01 |
| FCF Yield | -7.65% | 2.37% | 17.84% | -0.67% |
| EV / EBITDA | 4.99 | 7.55 | 1.82 | 2.89 |
| Quality | ||||
| ROIC | 1.89% | 1.91% | 2.99% | 6.68% |
| Gross Margin | 55.70% | 56.08% | 53.89% | 71.45% |
| Cash Conversion Ratio | -0.32 | 0.37 | 0.63 | -0.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 51.94% | 62.16% | 498.30% | 385.52% |
| Free Cash Flow Growth | -338.02% | -66.90% | 1,350.22% | -117.96% |
| Safety | ||||
| Net Debt / EBITDA | -1.77 | -1.70 | -1.35 | -0.26 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.09 | 0.09 | 0.12 | 0.08 |
| Cash Conversion Cycle | 1,125.21 | 1,165.19 | 950.83 | 1,218.20 |